global work
The Highest Leverage in Process Safety Is Where It Doesn’t Exist Yet
The developing world is building chemical and pharmaceutical manufacturing infrastructure at a pace that far outstrips its process safety governance capacity. These regions are today where the United States was before the process safety management frameworks of the 1990s were established — the hazards are the same, but the facilities are larger, and the consequences of failure scale accordingly.
The Opportunity
Development banks financing chemical and pharmaceutical infrastructure in the developing world require borrowing countries and companies to meet international process safety standards as a condition of funding. Designing those safety frameworks — and assessing whether facilities actually meet them — is built into the project cost. It is not grant-chasing. It is technical expertise the banks require, and the projects fund.
What Kenan Brings
The process safety governance frameworks that development banks, multinationals, and regulators require don’t exist in a vacuum — they are built on the same management system principles that Kenan has spent his career designing, evaluating, and co-authoring for CCPS. That expertise is directly transferable to capacity building programs, regulatory framework development, and supplier safety governance in emerging markets.
Delivery
For global programs, Kenan serves as program architect and senior technical advisor, partnering with in-country organizations for local implementation.
services
- Development bank program design and implementation
- Process safety capacity building programs for emerging market industries
- National regulatory framework development
- Multinational CMO supplier safety development programs
- IFC Performance Standards assessment for chemical and pharmaceutical facilities
- International training and knowledge transfer programs
regions
Kenan’s global focus follows the intersection of rapid industrial growth and underdeveloped process safety capacity:
South and Southeast Asia
(pharmaceutical CMO)
India, Vietnam, Indonesia, Bangladesh
Latin America
(petrochemical)
Brazil, Argentina, Mexico, Colombia
Sub-Saharan Africa
(industrial development)
Nigeria, Kenya, South Africa